145. Which is Better - Ozempic, Wegovy or Mounjaro? (Canadian Physician Perspective)
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
145. Which is Better - Ozempic, Wegovy or Mounjaro? (Canadian Physician Perspective)
-
ナレーター：
-
著者：
このコンテンツについて
Dr. Sasha High, Internal Medicine and Obesity Medicine physician, breaks down a common patient question: which GLP-1 medication is best for weight management?
On today’s episode, we review data for Ozempic (Semaglutide), Wegovy (Semaglutide 2.4mg) and Mounjaro (Tirzepatide) for obesity treatment. We discuss:
- Weight loss efficacy
- Blood sugar control for Type 2 diabetes
- Cardiovascular outcomes
- Other conditions such as chronic kidney disease and sleep apnea
Most relevant to the Canadian consumer is the discussion around insurance coverage and practical considerations like monthly cost.
Reminder that you still need to speak with your own healthcare provider about what treatment is most appropriate for you and this is for educational purposes only.
If you’re in Ontario and need support from a multidisciplinary team for chronic weight management, The High Metabolic Clinic is my program that offers holistic virtual care from obesity specialists, registered dietitians and psychotherapists across Ontario through telemedicine. You can get more info at www.highmetabolicclinic.com. We do need a referral from your Family Doctor.